Charting cognitive and volumetric trajectories after stroke: Protocol for the Cognition And Neocortical Volume After Stroke (CANVAS) study

International Journal of Stroke

Volumn 9, Issue 6, 2014, Pages 824-828

  Brodtmann, Amy ^a,b,c   Werden, Emilio ^a   Pardoe, Heath ^a,d   Li, Qi ^a   Jackson, Graeme ^a,b   Donnan, Geoffrey ^a   Cowie, Tiffany ^a   Bradshaw, Jennifer ^b   Darby, David ^a,e   Cumming, Toby ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b AUSTIN HEALTH   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^e ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Cognition; Cortical thickness; Dementia; Hippocampus; MRI; Stroke

Indexed keywords

AMYLOID; APOLIPOPROTEIN E;

AGING; ARTICLE; BRAIN ISCHEMIA; BRAIN SIZE; CAREGIVER; CLINICAL PROTOCOL; COGNITION; CONTROLLED STUDY; CORTICAL THICKNESS (BRAIN); DEMENTIA; GENETIC MARKER; HUMAN; MAJOR CLINICAL STUDY; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; STROKE PATIENT; BRAIN; COHORT ANALYSIS; COMPLICATION; LONGITUDINAL STUDY; METABOLISM; MOTOR ACTIVITY; ORGAN SIZE; PATHOLOGY; PATIENT SELECTION; PROGNOSIS; PSYCHOLOGY; SAMPLE SIZE; STROKE; TIME;

APOLIPOPROTEINS E; BRAIN; BRAIN ISCHEMIA; CLINICAL PROTOCOLS; COGNITION; COHORT STUDIES; DEMENTIA; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TESTS; ORGAN SIZE; PATIENT SELECTION; PROGNOSIS; SAMPLE SIZE; STROKE; TIME FACTORS;

EID: 84904686863     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/ijs.12301     Document Type: Article

References (37)

1. Prince M, Jackson J (eds). World Alzheimer's Report. London, Alzheimer's Disease International, 2009.
2. Mackay J, Mensah GA. The Atlas of Heart Disease and Stroke. Geneva, World Health Organization, 2007.
3. Pohjasvaara T, Erkinjuntti T, Vataja R, Kaste M. Dementia three months after stroke. Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort. Stroke 1997; 28:785-792.
4. Pohjasvaara T, Erkinjuntti T, Ylikoski R, Hietanen M, Vataja R, Kaste M. Clinical determinants of poststroke dementia. Stroke 1998; 29:75-81.
5. Suh GH, Kee BS. Prevalence of dementia in Asia: report of ASIADEM collaborative studies. Alzheimers Dement 2010; 6:S124.
6. Guerchet M, Houinato D, Mouanga AM etal. Risk factors for dementia in elderly living in three French-speaking African countries. Alzheimers Dement 2010; 6:S124.
7. Ferri CP, Prince M, Brayne C etal. Global prevalence of dementia: a Delphi consensus study. Lancet 2005; 366:2112-2117.
8. Savva GM, Stephan BC. Epidemiological studies of the effect of stroke on incident dementia: a systematic review. Stroke 2010; 41:e41-46.
9. Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol 2009; 8:1006-1018.
10. Jack CR Jr, Lowe VJ, Weigand SD etal. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain 2009; 132(Pt 5):1355-1365.
11. Jack CR Jr, Shiung MM, Weigand SD etal. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology 2005; 65:1227-1231.
12. Seshadri S, Wolf PA, Beiser A etal. Stroke risk profile, brain volume, and cognitive function: the Framingham Offspring Study. Neurology 2004; 63:1591-1599.
13. Elias MF, Beiser A, Wolf PA, Au R, White RF, D'Agostino RB. The preclinical phase of alzheimer disease: a 22-year prospective study of the Framingham Cohort. Arch Neurol 2000; 57:808-813.
14. Julkunen V, Niskanen E, Koikkalainen J etal. Differences in cortical thickness in healthy controls, subjects with mild cognitive impairment, and Alzheimer's disease patients: a longitudinal study. J Alzheimers Dis 2010; 21:1141-1151.
15. Du AT, Schuff N, Kramer JH etal. Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia. Brain 2007; 130(Pt 4):1159-1166.
16. Thompson PM, Hayashi KM, Sowell ER etal. Mapping cortical change in Alzheimer's disease, brain development, and schizophrenia. Neuroimage 2004; 23(Suppl. 1):S2-18.
17. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140:566-572.
18. Brodtmann A, Pardoe H, Li Q, Lichter R, Ostergaard L, Cumming T. Changes in regional brain volume three months after stroke. J Neurol Sci 2012; 322:122-128.
19. Nitkunan A, Lanfranconi S, Charlton RA, Barrick TR, Markus HS. Brain atrophy and cerebral small vessel disease: a prospective follow-up study. Stroke 2011; 42:133-138.
20. Hua X, Lee S, Hibar DP etal. Mapping Alzheimer's disease progression in 1309 MRI scans: power estimates for different inter-scan intervals. Neuroimage 2010; 51:63-75.
21. Srikanth VK, Quinn SJ, Donnan GA, Saling MM, Thrift AG. Long-term cognitive transitions, rates of cognitive change, and predictors of incident dementia in a population-based first-ever stroke cohort. Stroke 2006; 37:2479-2483.
22. Madden KP, Karanjia PN, Adams HP Jr, Clarke WR. Accuracy of initial stroke subtype diagnosis in the TOAST study. Trial of ORG 10172 in Acute Stroke Treatment. Neurology 1995; 45:1975-1979.
23. Bamford J, Sandercock P, Dennis M etal. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-86, 1: methodology, demography, and incident cases of first-ever stroke. J Neurol Neurosurg Psychiatry 1988; 51:1373-1380.
24. Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006; 166:1092-1097.
25. Jorm AF, Jacomb PA. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med 1989; 19:1015-1022.
26. Cummings JL. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology 1997; 48(5 Suppl. 6):S10-16.
27. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16:606-613.
28. Alderman N, Wood RL, Williams C. The development of the St Andrew's-Swansea Neurobehavioural Outcome Scale: validity and reliability of a new measure of neurobehavioural disability and social handicap. Brain Inj 2011; 25:83-100.
29. Hachinski V, Iadecola C, Petersen RC etal. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 2006; 37:2220-2241.
30. Benedict RHB, Schretlen D, Groniger L, Brandt J. The Hopkins Verbal Learning Test-Revised: normative data and analysis of interform and test-retest reliability. Clin Neuropsychol 1998; 12:43-55.
31. Lim YY, Jaeger J, Harrington K etal. Three-month stability of the CogState brief battery in healthy older adults, mild cognitive impairment, and Alzheimer's disease: results from the Australian Imaging, Biomarkers, and Lifestyle-rate of change substudy (AIBL-ROCS). Arch Clin Neuropsychol 2013; 28:320-330.
32. Cumming TB, Brodtmann A, Darby D, Bernhardt J. Cutting a long story short: reaction times in acute stroke are associated with longer term cognitive outcomes. J Neurol Sci 2012; 322:102-106.
33. Nelson HE. The National Adult Reading Test (NART): Test Manual. Windsor, UK, NFER-Nelson, 1982.
34. Nasreddine Z, inventor. The Montreal Cognitive Assessment - MoCA Copyright 2003-2013, 1996.
35. Pendlebury ST, Mariz J, Bull L, Mehta Z, Rothwell PM. MoCA, ACE-R, and MMSE versus the National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards Neuropsychological Battery after TIA and stroke. Stroke 2012; 43:464-469.
36. Boccardi M, Bocchetta M, Ganzola R etal. Operationalizing protocol differences for EADC-ADNI manual hippocampal segmentation. Alzheimers Dement 2013, doi: 10.1016/j.jalz.2013.03.001.
37. Wollenweber FA, Zietemann V, Rominger A etal. The Determinants of Dementia After Stroke (DEDEMAS) Study: protocol and pilot data. Int J Stroke 2014; 9:387-392.